|Articles|September 1, 2015
Considerations in the Development of Controlled Release Formulations
Author(s)Xcelience, LLC
Related Content
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
3
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
4
Investigating Patient Complaints About Combination Products
5